Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by Mole101on Aug 08, 2021 5:18pm
97 Views
Post# 33669905

RE:RE:RE:RE:Further Dilution of Shares

RE:RE:RE:RE:Further Dilution of Shares

   I find it rather amusing that those who have been cynical and down right nasty over the last few years. They are now trying to hold the flag of PMN and don't  like others to play in their box ...  This is a very small forum and pump/ bashing doesn't make a ripple on the sp..do your DD and asses your risk levels that's all Iwill worry about !! But then again is a good sport to rile up the crowds 


quote=goldtech]There you have it folks 4 cent David has told you where things are heading. He forgot to mention Biogens market cap went up by 40 Billion in one hour after phase one and what will happen to our Serology test when the CDC stops the PCR endorsement by year end, or our blood test for AD . Or . Or . Or. He is such a Bser and of course he will not admit it but he sold all his shares because next Friday he will buy back at under 20 cents. Lol he is so transparent.[/quote]
 

<< Previous
Bullboard Posts
Next >>